Literature DB >> 16034136

Neutrophil dysfunction in guanosine 3',5'-cyclic monophosphate-dependent protein kinase I-deficient mice.

Claudia G Werner1, Virginia Godfrey, Roland R Arnold, Gerald L Featherstone, Diane Bender, Jens Schlossmann, Matthias Schiemann, Franz Hofmann, Katherine B Pryzwansky.   

Abstract

The regulation of neutrophil functions by Type I cGMP-dependent protein kinase (cGKI) was investigated in wild-type (WT) and cGKI-deficient (cGKI-/-) mice. We demonstrate that murine neutrophils expressed cGKIalpha. Similar to the regulation of Ca2+ by cGKI in other cells, there was a cGMP-dependent decrease in Ca2+ transients in response to C5a in WT, but not cGKI-/- bone marrow neutrophils. In vitro chemotaxis of bone marrow neutrophils to C5a or IL-8 was significantly greater in cGKI-/- than in WT. Enhanced chemotaxis was also observed with cGKI-/- peritoneal exudate neutrophils (PE-N). In vivo chemotaxis with an arachidonic acid-induced inflammatory ear model revealed an increase in both ear weight and myeloperoxidase (MPO) activity in ear punches of cGKI-/- vs WT mice. These changes were attributable to enhanced vascular permeability and increased neutrophil infiltration. The total extractable content of MPO, but not lysozyme, was significantly greater in cGKI-/- than in WT PE-N. Furthermore, the percentage of MPO released in response to fMLP from cGKI-/- (69%) was greater than that from WT PE-N (36%). PMA failed to induce MPO release from PE-N of either genotype. In contrast, fMLP and PMA released equivalent amounts of lysozyme from PE-N. However, the percentage released was less in cGKI-/- (approximately 60%) than in WT (approximately 90%) PE-N. Superoxide release (maximum velocity) revealed no genotype differences in responses to PMA or fMLP stimulation. In summary, these results show that cGKIalpha down-regulates Ca2+ transients and chemotaxis in murine neutrophils. The regulatory influences of cGKIalpha on the secretagogue responses are complex, depending on the granule subtype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034136     DOI: 10.4049/jimmunol.175.3.1919

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Overexpression of cGMP-dependent protein kinase I (PKG-I) attenuates ischemia-reperfusion-induced kidney injury.

Authors:  Yanzhang Li; Xiaopeng Tong; Hasiyeti Maimaitiyiming; Kate Clemons; Ji-Min Cao; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Case-control genome-wide association study of attention-deficit/hyperactivity disorder.

Authors:  Benjamin M Neale; Sarah Medland; Stephan Ripke; Richard J L Anney; Philip Asherson; Jan Buitelaar; Barbara Franke; Michael Gill; Lindsey Kent; Peter Holmans; Frank Middleton; Anita Thapar; Klaus-Peter Lesch; Stephen V Faraone; Mark Daly; Thuy Trang Nguyen; Helmut Schäfer; Hans-Christoph Steinhausen; Andreas Reif; Tobias J Renner; Marcel Romanos; Jasmin Romanos; Andreas Warnke; Susanne Walitza; Christine Freitag; Jobst Meyer; Haukur Palmason; Aribert Rothenberger; Ziarih Hawi; Joseph Sergeant; Herbert Roeyers; Eric Mick; Joseph Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-08-05       Impact factor: 8.829

3.  Reduction of ICAM-1 expression by carbon monoxide via soluble guanylate cyclase activation accounts for modulation of neutrophil migration.

Authors:  Daniela Dal-Secco; Andressa Freitas; Monica A Abreu; Thiago P Garlet; Marcos A Rossi; Sérgio H Ferreira; João S Silva; José C Alves-Filho; Fernando Q Cunha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

4.  The Drosophila foraging gene human orthologue PRKG1 predicts individual differences in the effects of early adversity on maternal sensitivity.

Authors:  H Moriah Sokolowski; Oscar E Vasquez; Eva Unternaehrer; Dustin J Sokolowski; Stephanie D Biergans; Leslie Atkinson; Andrea Gonzalez; Patricia P Silveira; Robert Levitan; Kieran J O'Donnell; Meir Steiner; James Kennedy; Michael J Meaney; Alison S Fleming; Marla B Sokolowski
Journal:  Cogn Dev       Date:  2016-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.